Sponsor:
Simon Fraser University
Code:
NCT06336031
Conditions
Syncope, Vasovagal
Blood, Injection, Injury Type Phobia
Eligibility Criteria
Sex: All
Age: 18 - 50
Healthy Volunteers: Accepted
Interventions
blood-injection-injury (BII) phobia stimuli
neutral stimuli
Brief summary:
Conditions
Syncope, Vasovagal
Blood, Injection, Injury Type Phobia
Study ID
NCT06336031
Start date
Mar 30, 2024
Status verified date
May, 2025
Completion date
Dec, 2026
Anticipated
Primary completion date
Dec, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 50
Healthy Volunteers: Accepted
Enrollment
20 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Other
Arms
experimental: Image and video data set shown with BII stimuli.
placebo comparator: Image and video data set shown with neutral stimuli.
Interventions
blood-injection-injury (BII) phobia stimuli
neutral stimuli
Primary outcome measure
Central contacts
Locations
Simon Fraser University
Recruiting
Burnaby, British Columbia, Canada, V5A 1S6
Contacts
Principal Investigator:
Victoria E Claydon, PhD
Sponsor
Simon Fraser University
Last update posted
May 15, 2025
Last verified
May, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Simon Fraser University on 2025-05-15.